Fibromyalgia in men: comparison of psychological features with women.

Department of Medicine, University of Illinois College of Medicine at Peoria, One Illinois Drive, Peoria, IL 61605, USA.
The Journal of Rheumatology (Impact Factor: 3.17). 01/2005; 31(12):2464-7.
Source: PubMed

ABSTRACT To describe possible differences in psychological factors in men compared to women with fibromyalgia syndrome (FM).
Forty men and 160 women with FM were evaluated for anxiety, stress, and depression measured by ordinal scales and validated psychological instruments. Clinical and psychological variables were evaluated by a protocol.
Both men and women scored high in the psychological variables measured but the results were not significantly different between them.
There was no significant difference between men and women with FM in their psychological status.

Download full-text


Available from: Reyhan Celiker, Jun 23, 2015
1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives This study was the first to explore whether individuals with fibromyalgia (FM) have different cognitive alterations (i.e., in alertness, orienting, and executive control) depending on their sex. We also analysed possible gender differences in the relationships between cognitive functioning and some of the main symptoms of FM.DesignCross-sectional study.Methods Two clinical groups with FM (n = 58 women and n = 20 men) and two healthy control groups (n = 21 women and n = 27 men) aged between 30 and 60 years old participated in this study. Pain intensity, sleep disturbance, depression, anxiety, pain catastrophizing, and daily functioning were evaluated with self-report measures. Attentional function was assessed with the ANT-I task (Attentional Network Test-Interactions).ResultsMixed ANOVAs showed impairment in vigilance and executive control in both male and female patients with FM compared with controls. Control men were faster than control women, but FM eliminated sex differences. In addition, attention deficit was associated with worse daily functioning in women but not in men with FM. Emotional distress and sleep disruption seemed to contribute differently to these cognitive alterations in both sexes.Conclusions Therapy strategies aimed at reducing emotional distress and sleep disruption are likely to improve cognitive function by enhancing vigilance. Therapies aimed at reducing emotional distress seem to improve attentional function more in women than in men; those aimed at improving sleep quality are likely to reduce a vigilance/alertness deficit in women and executive problems in men.Statement of contribution What is already known on this subject? As the prevalence of FM is much lower in males than females, the literature about the syndrome has developed focusing basically on women. Before determining whether sex is an influential variable in the diagnosis and treatment of FM, it is essential to identify the characteristics of FM in women and men. No studies have analysed the cognitive function of men with FM. What does this study add? This study provides insight on the cognitive function of men with FM. We also found several interesting relationships between attentional indexes and clinical symptoms that are different according to sex. We suggest several implications of our findings for the management of this syndrome.
    British Journal of Health Psychology 12/2014; DOI:10.1111/bjhp.12128 · 2.70 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study is to examine gender differences in quality of life (QoL) and symptomatology in fibromyalgia (FM) patients. A total of 20 men (48.0 ± 8.0 years) and 78 women (49.8 ± 7.2 years) with FM participated in the study (age range 31-63 years). Health-related QoL and FM impact were assessed by means of the Spanish versions of the Short-Form-36 Health Survey (SF36) and the Fibromyalgia Impact Questionnaire (FIQ), respectively. Comparisons in QoL were performed using one-way analysis of covariance adjusted by age and body mass index (BMI), and comparisons in FIQ dimensions were performed using Mann-Whitney test. Overall FM impact, as measured by FIQ-total score (p = .01) and FIQ-physical impairment (p = .02) was higher in men, whereas women presented higher values of FIQ-fatigue and FIQ-morning tiredness (p = .04) and less SF36-vitality (p = .02). Therefore, women appear to feel more fatigue, whereas men present higher FM overall impact. Due to the small number of men included in this study and the consequent small statistical power, these results should be taken as preliminary. Higher powered studies are warranted to further address gender differences in FM in order to design more successful treatments.
    American journal of men's health 04/2012; 6(4):314-9. DOI:10.1177/1557988312436872 · 1.15 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Parte de la producción sobre género y salud realizada desde las ciencias sociales se ha centrado en el discurso médico hegemónico sobre la salud y el cuerpo de la mujer denunciando que la medicina científico occidental ha producido y reproducido valores sociales hegemónicos que han servido para justificar y legitimar una situación de inferioridad y de discriminación de la mujer. Dentro de este campo de estudio han tenido especial relevancia aquellos trabajos centrados en los discursos médicos versados explícitamente sobre la mujer, la reproducción y la sexualidad. En los últimos años éstos se han ampliado con otros que, partiendo de enfermedades y/o situaciones que afectan a ambos sexos y que resultan, por tanto, aparentemente neutrales, muestran la misma elaboración androcéntrica/sexista sobre la enfermedad y la mujer. Este es el caso de la fibromialgia, una enfermedad con alta prevalencia en mujeres. En este artículo se planteará cómo la fibromialgia ha sido gestada como una enfermedad en femenino y cómo a su vez esta caracterización ha supuesto una deslegitimación del síndrome y de las personas que la padecen.